In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final ...

Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Patients with platinum-sensitive relapsed ovarian cancer given maintenance olaparib/cediranib had similar progression-free ...

Zejula (niraparib) was approved for the treatment of patients with newly diagnosed ovarian cancer whose disease responded to chemotherapy. Patients can receive Zejula for up to three years after ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Foreman had “an inkling” that this mass was something more serious and unfortunately her instincts were right, and she was diagnosed with ovarian cancer. But after surgery to treat that ...

Scientists have pinpointed thousands of genetic changes in a gene that may increase a person's risk of developing breast and ...

New research identifies specific genetic changes that can increase a person's risk of breast and ovarian cancers, to help guide clinical decision-making.

15 Bianca Balti/Instagram Bianca Balti has been diagnosed with ovarian cancer. On Sunday, Sept. 15, the Sports Illustrated Swimsuit model, 40, shared a health update on Instagram that featured ...

Aug. 30 (UPI) --September is Ovarian Cancer Awareness Month and again this year efforts to raise awareness about the difficult-to-detect disease will be held across the country, starting with a ...